ZFP809 inhibitors represent a chemical class of molecules that modulate the activity of the zinc finger protein 809 (ZFP809), a transcription factor involved in gene regulation. ZFP809 is a member of the Krüppel-associated box (KRAB) domain-containing zinc finger proteins, which are known for their role in silencing transposable elements and retroviruses through the recruitment of transcriptional repressors. ZFP809 specifically binds to the proline-rich motif (PPXY) found in certain viral sequences, and its normal function involves suppressing the expression of foreign genetic elements by guiding repressive complexes to these regions in the genome. Inhibitors of ZFP809 interfere with this process, potentially altering the regulation of endogenous or exogenous gene sequences that are normally controlled by ZFP809.
The inhibition of ZFP809 activity can lead to alterations in chromatin structure and gene expression patterns due to the disruption of its role in gene silencing. Since ZFP809 typically associates with heterochromatin-forming complexes, inhibitors could affect the balance between euchromatic and heterochromatic regions within the genome. These changes could impact a range of cellular processes governed by chromatin dynamics, such as transcriptional regulation, epigenetic inheritance, and the overall maintenance of genome integrity. The study of ZFP809 inhibitors, therefore, provides important insights into understanding the broader mechanisms of transcriptional repression, retroelement control, and the functional consequences of modulating specific transcription factors involved in maintaining genomic stability.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor, potentially affecting gene expression regulated by ZNF809. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could alter DNA methylation, potentially impacting ZNF809 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor affecting protein degradation pathways, which might stabilize proteins regulating ZNF809. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor affecting various signaling pathways, possibly altering ZNF809 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor influencing cellular growth and proliferation, indirectly affecting ZNF809's role. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor that could impact cytoskeleton organization, potentially influencing ZNF809's cellular context. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor, which could indirectly affect transcription factors including ZNF809 by altering signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An ERK inhibitor potentially affecting pathways that regulate transcription factors like ZNF809. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
A JNK inhibitor, potentially impacting stress response pathways and indirectly affecting ZNF809's activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, affecting signaling pathways and potentially ZNF809's function. |